Zimigut 550 (Rifaximin) 550mg

Zimigut 550 (Rifaximin 550mg) is an antibiotic medication used to treat bacterial infections in the intestines. It belongs to the rifamycin class and works locally within the gut. This 100-tablet pack is stored at room temperature for convenience.

Strength

550mg

Pack Size

100s

Storage

Ambient

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Zimigut 550 is primarily used to address bacterial overgrowth in the small intestine and traveler's diarrhea caused by certain bacteria. It may also be prescribed for conditions like irritable bowel syndrome with diarrhea (IBS-D) when bacterial imbalance is suspected. The 550mg strength provides targeted action within the gastrointestinal tract.

Side Effects

Users often report reduced symptoms such as abdominal discomfort, bloating, and diarrhea after starting Zimigut 550. Some may notice improved regularity and fewer urgent bowel movements, though individual responses vary. The medication works locally in the gut without systemic absorption in most cases.

Precautions & Warnings

Store Zimigut 550 at room temperature away from moisture and heat. Keep the medication in its original packaging until use. If you experience persistent symptoms or new issues like severe diarrhea, consult a healthcare provider before continuing. Always follow the prescribed duration to avoid antibiotic resistance.

Avoid Interactions

Zimigut 550 has minimal systemic absorption, reducing the risk of interactions with other medications. However, concurrent use of certain antibiotics or immunosuppressants may require monitoring. Alcohol consumption does not typically interact with this medication but may worsen gastrointestinal symptoms.

Frequently Asked Questions

Zimigut 550 is used to treat bacterial overgrowth in the small intestine and traveler's diarrhea caused by specific bacteria.

Some users report symptom improvement within a few days, but the full course should be completed as prescribed.

It can be taken with or without food, but consistency in timing may help maintain steady effects.

Long-term use should only be under medical supervision to monitor for potential side effects or resistance.

Diarrhea is a symptom it treats, but some users may experience mild gastrointestinal effects during treatment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.